Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Prognostic impact of KRAS mutation subtype and concurrent genetic mutations in non-small cell lung cancer. Aredo, J., Padda, S., Kunder, C., Han, S. S., Wakelee, H. A. AMER SOC CLINICAL ONCOLOGY. 2018
View details for DOI 10.1200/JCO.2018.36.15_suppl.e21023
View details for Web of Science ID 000442916006490